rs752516966
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4BP6_Very_StrongBS2
The ENST00000370818.8(GPC3):āc.648G>Cā(p.Met216Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000736 in 1,209,855 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 30 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M216V) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000370818.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPC3 | NM_004484.4 | c.648G>C | p.Met216Ile | missense_variant | 3/8 | ENST00000370818.8 | NP_004475.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPC3 | ENST00000370818.8 | c.648G>C | p.Met216Ile | missense_variant | 3/8 | 1 | NM_004484.4 | ENSP00000359854 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000537 AC: 6AN: 111817Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33987
GnomAD3 exomes AF: 0.0000659 AC: 12AN: 182030Hom.: 0 AF XY: 0.0000594 AC XY: 4AN XY: 67310
GnomAD4 exome AF: 0.0000756 AC: 83AN: 1098038Hom.: 0 Cov.: 33 AF XY: 0.0000826 AC XY: 30AN XY: 363400
GnomAD4 genome AF: 0.0000537 AC: 6AN: 111817Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33987
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 17, 2020 | - - |
Wilms tumor 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2023 | - - |
Simpson-Golabi-Behmel syndrome type 1;CN033288:Wilms tumor 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 04, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at